Skip to main content
OpenTrials

Clinical trial condition

Non-Alcoholic Fatty Liver Disease

Explore clinical trials studying Non-Alcoholic Fatty Liver Disease. Study availability and eligibility vary by location and protocol.

326 public trials 55 recruiting studies
Refine in advanced search Browse all conditions

Non-Alcoholic Fatty Liver Disease trial results

Completed

Phase I Trial of Silymarin for Chronic Liver Diseases

NCT00389376

Conditions
Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +11 more
Locations
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
  • The University of North Carolina at Chapel Hill Chapel Hill, North Carolina, United States
  • University of Pennsylvania Philadelphia, Pennsylvania, United States
  • Thomas Jefferson University Philadelphia, Pennsylvania, United States
View Trial Details
Active, Not Recruiting

Phase 2b Study of GSK4532990 in Adults With NASH

NCT05583344

Conditions
Digestive System Diseases, Fatty Liver, Liver Diseases, +3 more
Locations
  • GSK Investigational Site Homewood, Alabama, United States
  • GSK Investigational Site Chandler, Arizona, United States
  • GSK Investigational Site Chandler, Arizona, United States
  • GSK Investigational Site Mesa, Arizona, United States
View all 170 locations
View Trial Details
Active, Not Recruiting

A Phase 3 Study to Evaluate Safety and Biomarkers of Resmetirom (MGL-3196) in Patients With Non-alcoholic Fatty Liver Disease (NAFLD), MAESTRO-NAFLD-Open-Label-Extension (MAESTRO-NAFLD-OLE)

NCT04951219

Conditions
Digestive System Diseases, Dyslipidemias, Endocrine System Diseases, +14 more
Locations
  • Central Research Associates Birmingham, Alabama, United States
  • Arizona Liver Health - Chandler Chandler, Arizona, United States
  • East Valley Family Physicians Chandler, Arizona, United States
  • The Institute For Liver Health - Glendale Glendale, Arizona, United States
View all 76 locations
View Trial Details

Related conditions